Bloqueio atrioventricular

Referências

Principais artigos

Kusumoto FM, Schoenfeld MH, Barrett C, et al. 2018 ACC/AHA/HRS guideline on the evaluation and management of patients with bradycardia and cardiac conduction delay: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation. 2019 Aug 20;140(8):e382-482.Texto completo  Resumo

Glikson M, Nielsen JC, Kronborg MB, et al; ESC National Cardiac Societies; ESC Scientific Document Group. 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Eur Heart J. 2021 Sep 14;42(35):3427-520.Texto completo  Resumo

Greenland P, Alpert JS, Beller GA, et al; American College of Cardiology Foundation, American Heart Association. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults. J Am Coll Cardiol. 2010;56:e50-103.Texto completo  Resumo

Artigos de referência

1. Josephson ME. Clinical cardiac electrophysiology: techniques and interpretations. 4th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2008.

2. Cheng S, Keyes MJ, Larson MG, et al. Long-term outcomes in individuals with prolonged PR interval or first-degree atrioventricular block. JAMA. 2009 Jun 24;301(24):2571-7.Texto completo  Resumo

3. Upshaw CB Jr. Comparison of the prevalence of first-degree atrioventricular block in African-American and in Caucasian patients: an electrocardiographic study III. J Natl Med Assoc. 2004 Jun;96(6):756-60.Texto completo  Resumo

4. DePaula RS, Antelmi I, Vincenzi MA, et al. Cardiac arrhythmias and atrioventricular block in a cohort of asymptomatic individuals without heart disease. Cardiology. 2007;108(2):111-6. Resumo

5. Du Z, Xing L, Lin M, et al. Prevalence of first-degree atrioventricular block and the associated risk factors: a cross-sectional study in rural Northeast China. BMC Cardiovasc Disord. 2019 Oct 7;19(1):214.Texto completo  Resumo

6. Kerola T, Eranti A, Aro AL, et al. Risk Factors Associated With Atrioventricular Block. JAMA Netw Open. 2019 May 3;2(5):e194176.Texto completo  Resumo

7. Kwok CS, Rashid M, Beynon R, et al. Prolonged PR interval, first-degree heart block and adverse cardiovascular outcomes: a systematic review and meta-analysis. Heart. 2016 May;102(9):672-80.Texto completo  Resumo

8. Kreger BE, Anderson KM, Kannel WB. Prevalence of intraventricular block in the general population: the Framingham Study. Am Heart J. 1989 Apr;117(4):903-10. Resumo

9. Smedema JP, Snoep G, van Kroonenburgh MP, et al. Cardiac involvement in patients with pulmonary sarcoidosis assessed at two university medical centers in the Netherlands. Chest. 2005;128:30-5. Resumo

10. Kusumoto FM, Schoenfeld MH, Barrett C, et al. 2018 ACC/AHA/HRS guideline on the evaluation and management of patients with bradycardia and cardiac conduction delay: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation. 2019 Aug 20;140(8):e382-482.Texto completo  Resumo

11. Tisdale JE, Chung MK, Campbell KB, et al. Drug-Induced Arrhythmias: A Scientific Statement From the American Heart Association. Circulation. 2020 Oct 13;142(15):e214-33.Texto completo  Resumo

12. Deisenhofer I, Zrenner B, Yin YH, et al. Cryoablation versus radiofrequency energy for the ablation of atrioventricular nodal reentrant tachycardia (the CYRANO Study): results from a large multicenter prospective randomized trial. Circulation. 2010 Nov 30;122(22):2239-45.Texto completo  Resumo

13. Ali H, Furlanello F, Lupo P, et al. Clinical and electrocardiographic features of complete heart block after blunt cardiac injury: a systematic review of the literature. Heart Rhythm. 2017 Jun 3;14(10):1561-9. Resumo

14. Silici S, Atayoglu AT. Mad honey intoxication: A systematic review on the 1199 cases. Food Chem Toxicol. 2015 Nov 10;86:282-90. Resumo

15. Royer A, van Veen TA, Le Bouter S, et al. Mouse model of SCN5A-linked hereditary Lenègre's disease: age-related conduction slowing and myocardial fibrosis. Circulation. 2005 Apr 12;111(14):1738-46.Texto completo  Resumo

16. Baruteau AE, Pass RH, Thambo JB, et al. Congenital and childhood atrioventricular blocks: pathophysiology and contemporary management. Eur J Pediatr. 2016 Sep;175(9):1235-48.Texto completo  Resumo

17. Rudbeck-Resdal J, Christiansen MK, Johansen JB, et al. Aetiologies and temporal trends of atrioventricular block in young patients: a 20-year nationwide study. Europace. 2019 Nov 1;21(11):1710-6.Texto completo  Resumo

18. Tracy CM, Epstein AE, Darbar D, et al. 2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. Heart Rhythm. 2012 Oct;9(10):1737-53.Texto completo  Resumo

19. Lenegre J. Etiology and pathology of bilateral bundle branch block in relation to complete heart block. Prog Cardiovasc Dis. 1964 Mar;6:409-44. Resumo

20. Lev M. Anatomic basis for atrioventricular block. Am J Med. 1964 Nov;37:742-8. Resumo

21. Zoob M, Smith KS. The aetiology of complete heart-block. Br Med J. 1963 Nov 9;2(5366):1149-53.Texto completo  Resumo

22. Glikson M, Nielsen JC, Kronborg MB, et al; ESC National Cardiac Societies; ESC Scientific Document Group. 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Eur Heart J. 2021 Sep 14;42(35):3427-520.Texto completo  Resumo

23. Simon AB, Steinke WE, Curry JJ. Atrioventricular block in acute myocardial infarction. Chest. 1972 Aug;62(2):156-61. Resumo

24. Ruiz-Bailén M, Pola Gallego MD, Expósito Ruiz M, et al. Atrioventricular block in unstable angina: results of the ARIAM registry [in Spanish]. Med Intensiva. 2006 Dec;30(9):432-9. Resumo

25. Hreybe H, Saba S. Location of acute myocardial infarction and associated arrhythmias and outcome. Clin Cardiol. 2009 May;32(5):274-7.Texto completo  Resumo

26. Amsterdam EA, Wenger NK, Brindis RG, et al; ACC/AHA Task Force Members. 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014 Dec 23;130(25):e344-426.Texto completo  Resumo

27. Kandolin R, Lehtonen J, Airaksinen J, et al. Cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25 years in a nationwide study. Circulation. 2015 Feb 17;131(7):624-32.Texto completo  Resumo

28. Chapelon-Abric C, de Zuttere D, Duhaut P, et al. Cardiac sarcoidosis: a retrospective study of 41 cases. Medicine (Baltimore). 2004 Nov;83(6):315-34. Resumo

29. Nordenswan HK, Lehtonen J, Ekström K, et al. Outcome of Cardiac Sarcoidosis Presenting With High-Grade Atrioventricular Block. Circ Arrhythm Electrophysiol. 2018 Aug;11(8):e006145.Texto completo  Resumo

30. Salama A, Abdullah A, Nadkarni A, et al. Sarcoidosis increases the risk of complete heart block: a review from the national inpatient sample. J Am Coll Cardiol. 2019 Mar;73(9 Suppl 1):543.Texto completo

31. Kandolin R, Lehtonen J, Salmenkivi K, et al. Diagnosis, treatment, and outcome of giant-cell myocarditis in the era of combined immunosuppression. Circ Heart Fail. 2013 Jan;6(1):15-22.Texto completo  Resumo

32. Matsumoto Y, Kubo T, Tagawa H, et al. An autopsy case of the sinus of Valsalva aneurysm involved with tuberculous inflammation, leading to complete heart block. [in jpn]. Kokyu To Junkan. 1993 Sep;41(9):911-5. Resumo

33. Yang KC, Hung CC, Ho YL. Tuberculous serositis coexisting with reversible high-grade atrioventricular block. Acta Cardiol Sin. 2005;21:164-8.Texto completo

34. Robinson ML, Kobayashi T, Higgins Y, et al. Lyme carditis. Infect Dis Clin North Am. 2015 Jun;29(2):255-68.Texto completo  Resumo

35. Puech P, Grolleau R, Buimond C. Incidence of different types of A-V block and their localization by His bundle recordings. In: Wellens HJ, Lie KI, Janse MJ, eds. The conduction system of the heart: structure, function, and clinical implications. Philadelphia, PA: Lea & Febiger; 1976:467-84.

36. Fenton AM, Hammill SC, Rea RF, et al. Vasovagal syncope. Ann Intern Med. 2000;133:714-725. Resumo

37. Kindermann M, Hennen B, Jung J, et al. Biventricular versus conventional right ventricular stimulation for patients with standard pacing indication and left ventricular dysfunction: the Homburg Biventricular Pacing Evaluation (HOBIPACE). J Am Coll Cardiol. 2006:47:1927-37.Texto completo  Resumo

38. Funck RC, Blanc JJ, Mueller HH, et al; BioPace Study Group. Biventricular stimulation to prevent cardiac desynchronization: rationale, design, and endpoints of the 'Biventricular Pacing for Atrioventricular Block to Prevent Cardiac Desynchronization (BioPace)' study. Europace. 2006;8:629-35.Texto completo  Resumo

39. McDonagh TA, Metra M, Adamo M, et al; ESC Scientific Document Group. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021 Sep 21;42(36):3599-726.Texto completo  Resumo

40. Sumiyoshi M, Nakata Y, Yasuda M, et al. Changes of conductivity in patients with second- or third-degree atrioventricular block after pacemaker implantation. Jpn Circ J. 1995;59:284-91. Resumo

41. Curtis AB, Worley SJ, Adamson PB, et al; Biventricular Versus Right Ventricular Pacing in Heart Failure Patients with Atrioventricular Block (BLOCK HF) Trial Investigators. Biventricular pacing for atrioventricular block and systolic dysfunction. N Engl J Med. 2013;368:1585-93.Texto completo  Resumo

42. Plotnikov AN, Shlapakova I, Szabolcs MJ, et al. Xenografted adult human mesenchymal stem cells provide a platform for sustained biological pacemaker function in canine heart. Circulation. 2007;116:706-13.Texto completo  Resumo

43. Farraha M, Kumar S, Chong J, et al. Gene therapy approaches to biological pacemakers. J Cardiovasc Dev Dis. 2018 Oct 19;5(4):50.Texto completo  Resumo

44. Goto H, Sugiura T, Harada Y, et al. Feasibility of using the automatic generating system for quartz watches as a leadless pacemaker power source. Med Biol Eng Comput. 1999;37:377-80. Resumo

45. Lee KL, Tse HF, Echt DS, et al. Temporary leadless pacing in heart failure patients with ultrasound-mediated stimulation energy and effects on the acoustic window. Heart Rhythm. 2009;6:742-8. Resumo

46. Lee KL, Lau CP, Tse HF, et al. First human demonstration of cardiac stimulation with transcutaneous ultrasound energy delivery: implications for wireless pacing with implantable devices. J Am Coll Cardiol. 2007;50:877-83.Texto completo  Resumo

47. Echt DS, Cowan MW, Riley RE, et al. Feasibility and safety of a novel technology for pacing without leads. Heart Rhythm. 2006;3:1202-6. Resumo

48. Reddy VY, Exner DV, Cantillon DJ, et al.; LEADLESS II Study Investigators. Percutaneous implantation of an entirely intracardiac leadless pacemaker. N Engl J Med. 2015;373:1125-35.Texto completo  Resumo

49. Greenland P, Alpert JS, Beller GA, et al; American College of Cardiology Foundation, American Heart Association. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults. J Am Coll Cardiol. 2010;56:e50-103.Texto completo  Resumo

50. Skinner M, Anderson J, Simms R, et al. Treatment of 100 patients with primary amyloidosis: a randomized trial of melphalan, prednisone, and colchicine versus colchicine only. Am J Med. 1996;100:290-8. Resumo

51. Santangeli P, Ferrante G, Pelargonio G, et al. Usefulness of statins in preventing atrial fibrillation in patients with permanent pacemaker: a systematic review. Europace. 2010;12:649-54. Resumo

O uso deste conteúdo está sujeito ao nosso aviso legal